Telcagepant

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTelcagepant
Drug Alias Name特卡戈潘telcagepant替卡吉泮Caprolactamazabenzimidazolone MerckTelcagepant potassium +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcitonin gene-related peptide antagonists
TargetsCalcitonin gene-related peptide
Therapy Area/IndicationsPeripheral Vascular DiseasesVascular DiseasesCoronary Disease +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLC
Active IndicationsN/A
Inactive IndicationsPeripheral Vascular DiseasesVascular DiseasesCoronary Disease +[8] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG